Myomo, Inc. (MYO)
NYSEAMERICAN: MYO · IEX Real-Time Price · USD
2.810
-0.270 (-8.77%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Myomo Market Cap
Myomo has a market cap or net worth of $80.97 million as of July 2, 2024. Its market cap has increased by 671.13% in one year.
Market Cap
80.97M
Enterprise Value
70.50M
1-Year Change
671.13%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since June 30, 2017, Myomo's market cap has increased from $66.00M to $80.97M, an increase of 22.68%. That is a compound annual growth rate of 2.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2024 | 81.00M | -39.01% |
| Dec 29, 2023 | 132.80M | 3,588.89% |
| Dec 30, 2022 | 3.60M | -92.34% |
| Dec 31, 2021 | 47.00M | 52.60% |
| Dec 31, 2020 | 30.80M | 492.31% |
| Dec 31, 2019 | 5.20M | -70.95% |
| Dec 31, 2018 | 17.90M | -21.83% |
| Dec 29, 2017 | 22.90M | -65.30% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 91.91M |
| Cardiff Oncology | 91.69M |
| Cellectar Biosciences | 91.41M |
| Asensus Surgical | 91.30M |
| Tiziana Life Sciences | 91.29M |
| Eton Pharmaceuticals | 87.35M |
| Protalix BioTherapeutics | 85.78M |
| Forian | 84.08M |